Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TELA Bio (TELA) EBT Margin (2018 - 2025)

TELA Bio (TELA) has 8 years of EBT Margin data on record, last reported at 41.58% in Q3 2025.

  • For Q3 2025, EBT Margin rose 1313.0% year-over-year to 41.58%; the TTM value through Sep 2025 reached 50.69%, up 1087.0%, while the annual FY2024 figure was 54.81%, 2502.0% up from the prior year.
  • EBT Margin reached 41.58% in Q3 2025 per TELA's latest filing, up from 48.97% in the prior quarter.
  • Across five years, EBT Margin topped out at 34.1% in Q1 2024 and bottomed at 138.81% in Q1 2021.
  • Average EBT Margin over 5 years is 83.82%, with a median of 80.45% recorded in 2023.
  • Peak YoY movement for EBT Margin: surged 7087bps in 2024, then crashed -2644bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 102.41% in 2021, then rose by 11bps to 91.32% in 2022, then rose by 12bps to 80.14% in 2023, then soared by 34bps to 52.99% in 2024, then increased by 22bps to 41.58% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 41.58% in Q3 2025, 48.97% in Q2 2025, and 60.54% in Q1 2025.